Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

2.970 -0.100 (-3.26%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
News headline image
GoodRx Announces New Affordability Programs for Menopause Hormone Therapies
From GoodRx
Via Business Wire
News headline image
GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers
From GoodRx
Via Business Wire
News headline image
GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call
From GoodRx Holdings, Inc.
Via Business Wire
News headline image
GoodRx Holdings Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) ↗
 
Via Benzinga
News headline image
GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray)
From GoodRx
Via Business Wire
News headline image
GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating GoodRx Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
GoodRx to Participate in Upcoming Investor Conferences
From GoodRx Holdings, Inc.
Via Business Wire
News headline image
GoodRx (GDRX) Q2 2024 Earnings Call Transcript ↗
GDRX earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
GoodRx Reports Q2 Earnings With Increased Prescription Revenue But Subscription Challenges ↗
GoodRx reported Q2 revenue of $200.61M, a 6% YoY increase. Prescription transactions revenue rose 7%, driven by 8% growth in Monthly Active Consumers. The company expects FY 2024 revenue at the lower... 
Via Benzinga
News headline image
GoodRx Reports Second Quarter 2024 Results
From GoodRx Holdings, Inc.
Via Business Wire
News headline image
MicroStrategy, Coinbase, Robinhood, Tesla And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
GoodRx Announces Date for Second Quarter 2024 Earnings Release and Conference Call
From GoodRx Holdings, Inc.
Via Business Wire
News headline image
Ian T. Clark Joins GoodRx Board of Directors
From GoodRx Holdings, Inc.
Via Business Wire
News headline image
3 Lawsuit-Laden Stocks to Dump Before Problems Multiply ↗
These stocks to sell face ongoing and past litigation, but that isn't the only sticking point in their long-term prospects. 
Via InvestorPlace
News headline image
Market Correction Alert: Sell These 3 Tech Stocks While You Can ↗
These tech stocks to sell combine shaky operational outlooks with underlying fundamental shakiness that don't bode well for the long-term. 
Via InvestorPlace
News headline image
GoodRx Launches New “Prescription Cost Tracker” to Spotlight Key Factors Driving Out-of-Pocket Medication Costs in the U.S.
From GoodRx
Via Business Wire
News headline image
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
GDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
GoodRx Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GDRX
From DJS Law Group
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against GoodRx Holdings, Inc. (GDRX)
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
GDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
GDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GoodRx, Exscientia, Malibu Boats, and Equinix and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
GDRX Investors Have Opportunity to Join GoodRx Holdings, Inc. Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
GOODRX HOLDINGS, INC. (NASDAQ: GDRX) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against GoodRx Holdings, Inc.
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
3 Stocks to Sell ASAP Before the June 27 Presidential Debate ↗
These stocks to sell sit within politically sensitive sectors, making them too risky to hold as we approach election season. 
Via InvestorPlace
News headline image
Rosen Law Firm Urges GoodRx Holdings, Inc. (GDRX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GoodRx, Exscientia, Malibu Boats, and Globe Life and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
GDRX INVESTOR ALERT: Kirby McInerney LLP Notifies GoodRx Holdings, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
From Kirby McInerney LLP
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.